Simcere Pharmaceutical Group. (SCR)
-NYSE 9.29 
0.03(0.32%) May 23, 4:09PM EDT
| Prev Close: | 9.26 |
|---|
| Open: | 9.24 |
|---|
| Bid: | 8.95 x 200 |
|---|
| Ask: | 17.00 x 300 |
|---|
| 1y Target Est: | 8.87 |
|---|
| Beta: | 0.13 |
|---|
| Next Earnings Date: | 5-Aug-13 |
|---|
| Day's Range: | 9.20 - 9.30 |
|---|
| 52wk Range: | 7.25 - 9.59 |
|---|
| Volume: | 7,488 |
|---|
| Avg Vol (3m): | 47,716 |
|---|
| Market Cap: | 488.45M |
|---|
| P/E (ttm): | 53.39 |
|---|
| EPS (ttm): | 0.17 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Scor First-Quarter Net Rises 6.7% on Fewer Natural Catastrophesat Bloomberg(Wed, May 15)
- 3 Healthcare Stock Winners and 1 Loser After Earnings Are Digestedat Wall St. Cheat Sheet(Sun, May 12)
- Simcere Beats 1Q Earnings & Revenue EstimateZacks(Fri, May 10)
- Simcere Pharmaceutical's CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Thu, May 9)
- Simcere Pharmaceutical Earnings: Everything You Must Know Nowat Wall St. Cheat Sheet(Thu, May 9)
- Simcere Pharmaceutical Group Earnings Call scheduled for 8:00 am ET todayCCBN(Thu, May 9)
- Q1 2013 Simcere Pharmaceutical Group Earnings Release - Before Market OpenCCBN(Thu, May 9)
- Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2013 ResultsPR Newswire(Thu, May 9)
- Simcere Pharmaceutical Group. Earnings: What Investors Should Watchat Wall St. Cheat Sheet(Wed, May 8)
- SIMCERE PHARMACEUTICAL GROUP FinancialsEDGAR Online Financials(Wed, May 1)
- Simcere Pharmaceutical Group Filed 2012 Annual Report on Form 20-FPR Newswire(Sat, Apr 27)
- Simcere Pharmaceutical Group to Announce First Quarter 2013 Financial Results on Thursday, May 9, 2013PR Newswire(Fri, Apr 26)
- Some Numbers at Simcere Pharmaceutical Group. that Make Your Stock Look Goodat Motley Fool(Thu, Apr 11)
- Here's 1 Reason Simcere Pharmaceutical Group. Looks Weakat Motley Fool(Thu, Apr 4)
- Simcere Pharmaceutical Group Announces its Special Committee's Engagement of Financial AdvisorPR Newswire(Wed, Apr 3)
Key Statistics
| Forward P/E (1 yr): | 21.60 |
|---|
| P/S (ttm): | 1.44 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.39 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.12 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | -11.73 |
|---|
Business Summary
Simcere Pharmaceutical Group engages in the research, development, manufacture, and distribution of pharmaceutical and vaccine products for pharmaceutical distributors and government in the Peoples Republic of China.
View More